Search results
Cochlear implants aid Meniere disease outcomes, study shows
Medical Xpress· 12 hours agoCochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in...
Charlotte, the pregnant stingray with no male partner, has a 'rare reproductive disease'
AOL· 17 hours agoA female stingray who gained national attention after she became pregnant despite not sharing a tank...
Oregon Report Keys in on Disabling Claims for Occupational Injuries
Insurance Journal· 43 minutes agoOregon's Department of Consumer and Business Services received notification of 24,947 accepted...
Lyme Disease recovery workshop at the Old Forge Library
Rome Sentinel· 15 hours agoJessica Maureen Hinsdill will lead the informative workshop LymeDisease — Improving Recovery with...
No causal association seen for Meniere disease, migraine
Medical Xpress· 18 hours agoMigraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine,...
Grand Rapids hospital offering new treatment for Alzheimer's Disease
WZZM 13 Grand Rapids· 14 hours agoTrinity Health Grand Rapids says it's the first in West Michigan to offer a lecanemab, a treatment...
Brandt: Improving support & care for dementia caregivers
Boston Herald· 2 hours ago“Overwhelming” is rarely an understatement, but for families caring for loved ones with dementia,...
Findings from studies presented at Digestive Disease Week
Medical Xpress· 18 hours agoDigestive Disease Week, the annual meeting sponsored by the American Association for the Study of...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 24 minutes agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
Annexon’s neurological disease drug meets main goal of late-stage study
WSAU Wausau· 18 hours ago(Reuters) -Annexon said on Tuesday its experimental drug to treat a rare neurological disease met the main goal of a late-stage trial, sending its shares up more than 31% ...